These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

846 related items for PubMed ID: 24095631

  • 1. Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease.
    Tomaschitz A, Ritz E, Pieske B, Rus-Machan J, Kienreich K, Verheyen N, Gaksch M, Grübler M, Fahrleitner-Pammer A, Mrak P, Toplak H, Kraigher-Krainer E, März W, Pilz S.
    Metabolism; 2014 Jan; 63(1):20-31. PubMed ID: 24095631
    [Abstract] [Full Text] [Related]

  • 2. Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease.
    Tomaschitz A, Ritz E, Pieske B, Fahrleitner-Pammer A, Kienreich K, Horina JH, Drechsler C, März W, Ofner M, Pieber TR, Pilz S.
    Cardiovasc Res; 2012 Apr 01; 94(1):10-9. PubMed ID: 22334595
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors?
    Anderson JL, Vanwoerkom RC, Horne BD, Bair TL, May HT, Lappé DL, Muhlestein JB.
    Am Heart J; 2011 Aug 01; 162(2):331-339.e2. PubMed ID: 21835295
    [Abstract] [Full Text] [Related]

  • 6. PTH Modulation by Aldosterone and Angiotensin II is Blunted in Hyperaldosteronism and Rescued by Adrenalectomy.
    Lenzini L, Prisco S, Vanderriele PE, Lerco S, Torresan F, Maiolino G, Seccia TM, Iacobone M, Rossi GP.
    J Clin Endocrinol Metab; 2019 Sep 01; 104(9):3726-3734. PubMed ID: 30865228
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 01; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 9. Factors affecting parathyroid hormone levels in different types of primary aldosteronism.
    Jiang Y, Zhang C, Ye L, Su T, Zhou W, Jiang L, Zhang Y, Wang W.
    Clin Endocrinol (Oxf); 2016 Aug 01; 85(2):267-74. PubMed ID: 26589237
    [Abstract] [Full Text] [Related]

  • 10. Parathyroid Gland Function in Primary Aldosteronism.
    Asbach E, Bekeran M, Reincke M.
    Horm Metab Res; 2015 Dec 01; 47(13):994-9. PubMed ID: 26667802
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Serum aldosterone is correlated positively to parathyroid hormone (PTH) levels in patients with primary hyperparathyroidism.
    Brunaud L, Germain A, Zarnegar R, Rancier M, Alrasheedi S, Caillard C, Ayav A, Weryha G, Mirallie E, Bresler L.
    Surgery; 2009 Dec 01; 146(6):1035-41. PubMed ID: 19958930
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Interplay of parathyroid hormone and aldosterone antagonist in prevention of heart failure hospitalizations in chronic kidney disease.
    Hassan M, Qureshi W, Sroujieh LS, Albashaireh D, BouMalham S, Liroff M, Amjad W, Khalid F, Hadid H, Alirhayim Z.
    J Renin Angiotensin Aldosterone Syst; 2014 Sep 01; 15(3):278-85. PubMed ID: 25002131
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Long-term control of parathyroid hormone and calcium-phosphate metabolism after parathyroidectomy in children with chronic kidney disease.
    Schaefer B, Schlosser K, Wühl E, Schall P, Klaus G, Schaefer F, Schmitt CP.
    Nephrol Dial Transplant; 2010 Aug 01; 25(8):2590-5. PubMed ID: 20181803
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Parathyroid hormone, aldosterone-to-renin ratio and fibroblast growth factor-23 as determinants of nocturnal blood pressure in primary hyperparathyroidism: the eplerenone in primary hyperparathyroidism trial.
    Verheyen N, Fahrleitner-Pammer A, Pieske B, Meinitzer A, Belyavskiy E, Wetzel J, Gaksch M, Grübler MR, Catena C, Sechi LA, Van Ballegooijen AJ, Brandenburg VM, Scharnagl H, Perl S, Brussee H, März W, Pilz S, Tomaschitz A.
    J Hypertens; 2016 Sep 01; 34(9):1778-86. PubMed ID: 27379537
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.